InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Marsh Linda, 董事. Director active across 3 companies, notably Fulgent Genetics, Inc.. Aggregated, 14 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €8.8m. History available since 20 May 2021. The latest transaction was disclosed on 3 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Marsh Linda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
20,000 股@ US$18.2067.3% 占其流量Common StockSEC:0001104659-25-107189:0
6,449 股0Common StockSEC:0001104659-25-059377:0
8,982 股0Common StockSEC:0000950170-25-074718:0
11,000 股@ US$15.35100.0% 占其流量Common StockSEC:0001104659-24-099376:0
3,564 股0Common StockSEC:0001104659-24-089699:0
8,000 股0Common StockSEC:0000950170-24-062569:0
3,650 股0Common StockSEC:0001104659-23-126904:0
5,059 股0Common StockSEC:0001209191-23-031477:0
270,081 股@ US$35.3248.7% 占其流量Common StockSEC:0001628280-23-008109:0
62,500 股@ US$10.003.2% 占其流量Common StockSEC:0001250853-23-000009:0
1,600 股0Common StockSEC:0001209191-22-044294:0
250,000 股@ US$37.00100.0% 占其流量Common StockSEC:0001104659-22-072514:0
2,000 股0Common StockSEC:0001209191-22-030961:0
2,000 股0Common StockSEC:0001209191-21-035452:0
14 条申报中的 14 条
About Marsh Linda
Linda Marsh is Administrateur at Fulgent Genetics, Inc., Astrana Health, Inc. and Apollo Medical Holdings, Inc. She has 14 filings in total, and across the sampled recent filings from 2021-05-24 to 2025-11-05, sales total EUR 17664794 and the most common transaction nature is Attribution.
